General Information of Drug (ID: DMWZ27A)

Drug Name
8-methyl-2-morpholino-7-phenoxy-4H-chromen-4-one
Synonyms CHEMBL203942
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 337.4
Logarithm of the Partition Coefficient (xlogp) 3.4
Rotatable Bond Count (rotbonds) 3
Hydrogen Bond Donor Count (hbonddonor) 0
Hydrogen Bond Acceptor Count (hbondacc) 5
Chemical Identifiers
Formula
C20H19NO4
IUPAC Name
8-methyl-2-morpholin-4-yl-7-phenoxychromen-4-one
Canonical SMILES
CC1=C(C=CC2=C1OC(=CC2=O)N3CCOCC3)OC4=CC=CC=C4
InChI
InChI=1S/C20H19NO4/c1-14-18(24-15-5-3-2-4-6-15)8-7-16-17(22)13-19(25-20(14)16)21-9-11-23-12-10-21/h2-8,13H,9-12H2,1H3
InChIKey
OOXOMHKMWGSWSD-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
23586753
TTD ID
D08WIJ

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Phosphodiesterase 3A (PDE3A) TT06AWU PDE3A_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Phosphodiesterase 3A (PDE3A) DTT PDE3A 3.33E-01 1.35E-02 0.14
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 Analysis of anti-PDE3 activity of 2-morpholinochromone derivatives reveals multiple mechanisms of anti-platelet activity. Bioorg Med Chem Lett. 2006 Feb 15;16(4):969-73.